Previous Pause Next
Home >> News Center >>
Quelling Casimir: Scientists to Control Quantum Mechanical Force PDF Print E-mail
User Rating :  / 0
Friday, 01 January 2010 00:43
Scientists at the U.S. Department of Energy's Argonne National Laboratory are developing a way to control the Casimir force, a quantum mechanical force that attracts objects when they are only hundred nanometers apart.

"The Casimir force is so small that most experimentation has dealt simply with its characteristics," said Derrick Mancini, interim director of the Center for Nanoscale Materials. "If we can control this force or make it repulsive, it can have dramatic effects on the development of nanoelectromechanical systems."

Nanoelectromechanical systems (NEMS) are nano-meter size mechanical devices that can be used for actuation or sensing at the nano-scale. Many NEMS devices are currently being developed for unique applications in sensing, telecommunications, signal processing, data storage, and more. In the macro world, the Casimir force is so small that it can be barely detected, but at the nanoscale it becomes a quantum effect that scientists cannot currently control.

"As characteristic device dimensions shrink to the nanoscale, the effects of the attractive Casimir force becomes more pronounced making very difficult to control nano-devices. This is a technological challenge that need to be addressed before the full potential of NEMS devices can be demonstrated," scientist Daniel Lopez said. "The goal is to not only limit its attractive properties, but also to make it repulsive. A repulsive force acting at the nano-scale would allow engineers to design novel NEMS devices capable of frictionless motion through nanolevitation."

The approach to controlling this force involves nanostructuring the interacting surfaces to tune the effects of the Casimir force.

Argonne National Laboratory was recently selected by the Defense Advanced Research Projects Agency (DARPA) to develop mechanisms to control and manipulate the Casimir force. This program will be developed in close partnership with Indiana University Purdue University Indianapolis, NIST and Los Alamos National Laboratory.

The Center for Nanoscale Materials at Argonne National Laboratory is one of the five DOE Nanoscale Science Research Centers (NSRCs), premier national user facilities for interdisciplinary research at the nanoscale, supported by the DOE Office of Science. Together, the NSRCs comprise a suite of complementary facilities that provide researchers with state-of-the-art capabilities to fabricate, process, characterize and model nanoscale materials, and constitute the largest infrastructure investment of the National Nanotechnology Initiative. The NSRCs are located at DOE's Argonne, Brookhaven, Lawrence Berkeley, Oak Ridge, Sandia and Los Alamos national laboratories.

Adapted from materials provided by DOE/Argonne National Laboratory.

 
FairExcellent 

Add comment  |   Add to my library  |  Forward this article

login to leave comment

Biomarkers & Drug Targets

Scripps research scientists elevate little-studied cellular mechanism to potential drug target

New advance announced in reducing 'bad' cholesterol

Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer

New gene study of ADHD points to defects in brain signaling pathways

Inhibitors of infamous Ras oncogene reported by Genentech researchers at ASCB annual meeting

SRI Researchers Validate Preclinical Effectiveness of Tuberculosis Drug Target that Could Shorten Treatment Time

New potential therapeutic target identified for Diffuse Large B-Cell Lymphoma

Vitamin D–fortified yoghurt improves cholesterol levels and heart disease biomarkers for diabetics

U-M researchers find genetic rearrangements driving 5 to 7 percent of breast cancers

Researchers discover genes involved in colorectal cancer

>> More in: Biomarkers & Drug Targets

Systems Bio & Personalized Med

New trial model unlocks power of personalized medicine

UPMC to Build $300M Center for 'Innovative' Biomedical Science

Manchester's 'first step' to perfect drug combinations

Good Start Genetics? Announces Validation Results For Its Next-Generation DNA Sequencing Platform For Genetic Disorder Carrier Screening

Young Genes Correlated With Evolution Of Human Brain

UGA Scientists Team Up To Define First-Ever Sequence Of Biologically Important Carbohydrate

Cells Are Crawling All Over Our Bodies, But How?

First-Ever Sequence and Structure of Biologically Important Carbohydrate

New Gene Therapy Methods Accurately Correct Mutation In Patient's Stem Cells, Bringing Personalized Cell Therapies One Step Closer

Cells Have Early-Warning System for Intruders

>> More in: Systems Bio & Personalized Med, Systems Bio & Personalized Med

Bio-Chip & Nanotechnology

Getting Cancer Cells to Swallow Poison: Nanotechnology Researchers Develop New Strategy to Deliver Chemotherapy to Prostate Cancer Cells

OU researchers target cancer with nanoparticles

UCLA physicists report nanotechnology feat with proteins

Lightning-fast, efficient data transmission developed at Stanford

A realistic look at the promises and perils of nanomedicine

Berkeley Lab Researchers Ink Nanostructures with Tiny ‘Soldering Iron’

Study indicates nanoparticles could help pain-relieving osteoarthritis drugs last longer

Mobile Electrons Multiplied in Quantum Dot Films

Could a Computer One Day Rewire Itself? New Nanomaterial 'Steers' Electric Currents in Multiple Dimensions

Nano Funnel Used to Generate Extreme Ultraviolet Light Pulses

>> More in: Bio-Chip & Nanotechnology

Biomedical Imaging

Penn engineers develop more effective MRI contrast agent for cancer detection

PET Technique Promises Better Detection and Therapy Response Assessment for a Deadly Form of Non-Hodgkin’s Lymphoma

A single cell endoscope

Yale researchers develop a way to monitor engineered blood vessels as they grow in patients

Integrated 3-D imaging facilitates human face transplantation

Combined arterial imaging technology reveals both structural and metabolic details

Cornell Reaches Two Milestones toward a New Coherent X-ray Source

Test Combination Helps Predict Alzheimer's Disease Risk

New Instrument Helps Researchers See How Diseases Start And Develop In Minute Detail

Trio of Studies Support Use of PET/CT Scans as Prostate Cancer Staging Tool

>> More in: Biomedical Imaging